蚌埠招聘

Responsibilities:
1. Lead, mentor, and manage a group of analytical scientists to support early CMC development for customers.
2. Define and optimize the work processes within the department, and coordinate cross-functional project teams to ensure the development services meet customers' quality requirements and timelines.
3. Partcipate in decision-making process with senior management on budgeting, planning, and implementation.
4. Initiate, develop, and foster a long-term partnership with customers.
5. Manage the daily operations and activities within the department. Provide training and technical guidance to scientists to ensure the quality of work and timely completion of projects as required.
6. Be responsible for departmental performance and individual performance evaluations.
7. Create, review, approve, and implement SOPs within the department.
8. Maintain a safe and compliant work environment.
9. Lead analytical groups in site to support chemical development activities in both pilot plant and kilo-labs.
10. Manage the daily activities including method development and validation, in-process control and routine sample analysis, review experimental results and reports, problem-solving, and teleconference with customers.

Requirements:
1. Education in analytical chemistry, organic chemistry, or related disciplines.
2. Have a degree of Ph.D. with 3 - 10 years of technical and managerial experience in pharmaceutical industry.
3. Be familiar with overall pharmaceutical development process, cGMP and regulatory guidelines.
4. Hands-on method development experience and in-depth knowledge of chromatographic techniques such as HPLC, LC-MS, GC, GC-MS, chiral separations, NMR, IR,and chemical and structural characterizations.
5. Have excellent communication and interpersonal skills.
6. Fluent in Chinese and English.

关于保诺-桑迪亚

保诺-桑迪亚，安宏资本旗下投资企业之一，是业内领先的合同研究、工艺开发和生产公司 (CRDMO)，专业为生物制药客户提供全面整合服务，支持药物发现、开发和生产（包括原料药和成品药）。作为全球第三大 CRDMO 公司，保诺-桑迪亚的 10 大办事处遍布全球，旗下拥有 2000 多名员工，在中国和美国开展主要业务。

保诺-桑迪亚在大小分子发现、开发和放大方面拥有核心专业知识，支持 IND 申报，拥有独特的专利技术平台（例如不溶性化合物生物利用度增强平台）。公司在中国和美国均设有研发中心和生产基地。保诺-桑迪亚采用“一站式”运营模式，有效帮助生物制药客户加快发现进程并降低开发风险，从而创造更高价值的药物。

保诺-桑迪亚由安宏资本领投，Bridgewest Business Group 为共同投资者。